hemodynamic measurements

Related by string. * hemodynamics . Hemodynamic . Hemodynamics : hemodynamic parameters . hemodynamic instability . acute hemodynamic monitoring . hemodynamic responses . hemodynamic variables / MEASUREMENT . Measurements . MEASUREMENTS . Measurement : Audience Measurement . quantitative measurements . Measurement Specialties . Measurement Specialties Inc. . precise measurements * *

Related by context. All words. (Click for frequent words.) 66 venous thromboembolic disease 66 demonstrated clinically meaningful 65 intravascular hemolysis 65 pharmacodynamic parameters 65 ADCS CGIC 65 Primary endpoints 65 tissue oxygenation 64 Skin sterol 64 hemostatic efficacy 64 myocardial infarction ventricular fibrillation 64 mild hepatic impairment 64 deep venous thromboses 64 organ perfusion 64 indicates cardio circulatory 63 Tumor Response 63 cerebral oximetry 63 Secondary endpoints included 63 postoperative AF 63 Secondary endpoints include 63 cerebral oxygenation 63 Symptom severity 63 prespecified secondary 63 ambulatory settings 63 nonfatal myocardial infarction MI 63 symptomatic intracranial 63 transesophageal 63 Efficacy endpoints 63 hemodynamic parameters 63 clevidipine 63 CPAP adherence 62 Coronary CTA 62 tissue perfusion 62 hepatic insufficiency 62 left ventricular diastolic 62 coagulation abnormalities 62 Multivariate logistic regression 62 SpO2 pulse rate 62 EQ 5D 62 Fibromyalgia Impact Questionnaire 62 myocardial function 62 haematologic 62 echocardiographic parameters 62 EORTC QLQ C# 62 gastroduodenal 62 morphometric vertebral fractures 62 haemodynamic 62 pharmacodynamic PD 62 pulmonary artery banding 62 Echocardiographic 62 tracheal intubation 62 descending thoracic 62 defibrillator implantation 62 exploratory endpoints 61 preoperative intraoperative 61 FluCAM arm 61 Secondary efficacy endpoints 61 dermatologic reactions 61 Vascugel ® 61 Cardiotoxicity 61 cervicitis 61 WOMAC pain 61 BPS IC 61 CentriMag 61 CINQUIL 61 pulmonary capillary wedge 61 Diabetic Foot Ulcer 61 relapsed MM 61 ANCA associated 61 PLX STROKE targeting 61 antiplatelet medications 61 esophageal reflux 61 BEXXAR Therapeutic Regimen 61 functional mitral regurgitation 61 convulsive disorders 61 neurosensory 61 ionotropic 61 gynecologic procedures 61 aMCI precursor 61 Eisenmenger syndrome 61 Glomerular Filtration Rate 61 angiographic outcomes 61 Tasigna prolongs 61 esophagogastric 61 Coronary Artery Bypass Graft 61 vitreous floaters 61 hematological parameters 61 Cardiopulmonary bypass 61 unstable angina pectoris 61 anemia thrombocytopenia 61 pulmonary infiltrates 61 Warfarin Coumadin 61 dyslipidemia hypertension diabetes 61 mild renal insufficiency 60 Myocardial Perfusion Imaging 60 kidney urologic 60 radiotherapy RT 60 artery stenosis 60 Vasotrac 60 procedural sedation 60 Doppler echocardiography 60 sacral nerve stimulation 60 underwent coronary angiography 60 somatosensory evoked potentials 60 REMINYL ® 60 hemodilution 60 Cardiac Resynchronization 60 Erythropoietic therapies may 60 corticosteroid induced 60 serum phosphorous 60 cerebral perfusion 60 SF #v# 60 FFR measurements 60 calculated creatinine clearance 60 MGuard ™ 60 tolerability pharmacokinetics 60 urine albumin 60 thromboembolic complications 60 Acutely ill 60 transrectal ultrasound guided 60 bronchial hyperresponsiveness 60 Perforomist ™ Inhalation Solution 60 Coronary Angiography 60 activated partial thromboplastin 60 tibial shaft 60 corticosteroid dose 60 recurrent DVT 60 AST ALT 60 Visensia 60 transcranial Doppler 60 prehospital setting 60 transthoracic 60 hepatic arterial 60 venous stasis ulcers 60 Ejection Fraction 60 cardioverter defibrillator 60 HIV HCV coinfected 60 cardiac resynchronisation therapy 60 angiographically 60 NHAMCS 60 mean ± SEM 60 systemic hypotension 60 Histologic 60 ATACAND 60 Cardiorespiratory fitness 60 postoperative complication 60 Sonographic 60 glycosylated hemoglobin HbA1c 60 hemodynamic variables 60 Hypertrophy 60 Secondary Hyperparathyroidism 60 Bronchopulmonary Dysplasia 60 bronchoalveolar lavage BAL 60 nicardipine 60 catheter occlusion 60 undergoing elective percutaneous 59 sonographically guided 59 Secondary endpoints 59 Renal dysfunction 59 NATRECOR ® 59 arterial oxygen saturation 59 reactogenicity 59 Carotid endarterectomy 59 cardiac perfusion 59 hepatic lesions 59 Functional Outcomes 59 Multidetector CT 59 Echocardiogram 59 hemodynamically stable 59 proton MR spectroscopy 59 ICAEL 59 Patients Receiving 59 antiplatelet therapies 59 calcaneal fractures 59 ratio WHR 59 Provent Therapy 59 mitral insufficiency 59 fractional shortening 59 meta regression 59 electrophysiologic 59 Patency 59 Negative Symptoms 59 postoperative infections 59 SIADH 59 cardiac repolarization 59 thoracentesis 59 ischemic mitral regurgitation 59 alfuzosin 59 afterload 59 prospective multicenter study 59 inhaled bronchodilators 59 urolithiasis 59 contrast echocardiography 59 percutaneous vertebroplasty 59 Suboptimal 59 Ankle Brachial Index 59 Hemodynamic 59 aspirin clopidogrel 59 coronary intervention 59 CMV reactivation 59 receiving XGEVA 59 symptomatic hyponatremia 59 waist circumference WC 59 Catheter Associated 59 Renal Artery 59 hypoventilation 59 chronic thromboembolic pulmonary 59 prospectively stratified 59 Scintigraphy 59 symptomatic VTE 59 Pediatric Patients 59 coronary revascularization procedures 59 hemodynamics 59 irinotecan cisplatin 59 ß blockers 59 convergent validity 59 clinicopathologic 59 Arteriovenous 59 either acutely decompensated 59 cartilage lesions 59 progressive dyspnea 59 PCWP 59 Adverse effects 59 aldosterone antagonist 59 DLQI 59 NPM1 mutation 59 vascular endothelial dysfunction 59 certolizumab 59 myocardial viability 59 hepatorenal syndrome 59 cytomegalovirus infection 59 Lewy bodies DLB 59 Known hypersensitivity 59 deCODE AF TM 59 Global Impression CGI 59 clinicopathological features 59 Brief Psychiatric 59 STRATEGY FOR AN OPEN 59 hyperphenylalaninemia HPA due 59 radiographic outcomes 59 Electroencephalography 59 electrocardiographs 59 macular edema secondary 59 Orthostatic Hypotension 59 levodopa induced 59 Pulse Oximetry 58 oral anticoagulant therapy 58 GI motility disorders 58 chest radiographs 58 perfusion abnormalities 58 Comorbidities 58 intra abdominal abscess 58 nasopharyngitis headache 58 Myocardial Perfusion 58 Prospective Randomized 58 reintubation 58 Ultrasonographic 58 CORE OM 58 Aeolus Pharmaceuticals Announces 58 neutropenia dehydration dyspnea 58 LV ejection fraction 58 renal cortical 58 pulmonary exacerbations 58 thoracolumbar spine 58 access graft VAG 58 angioplasty stenting 58 CT Angiography 58 severe hepatic dysfunction 58 untreated OSA 58 perioperative mortality 58 Secca System 58 Pelvic Organ Prolapse 58 inhaled iloprost 58 Comorbidity 58 postoperative hemorrhage 58 Left Ventricular 58 interobserver 58 vascular insufficiency 58 Ventricular Arrhythmias 58 duplex ultrasonography 58 aminotransferases 58 poststroke 58 oral antidiabetic medication 58 clinico pathological 58 Who Underwent 58 CIMZIA TM certolizumab pegol 58 myopathy rhabdomyolysis 58 angina myocardial infarction 58 QTc intervals 58 diabetic polyneuropathy 58 Transurethral 58 bronchoalveolar lavage 58 unresectable tumors 58 cholestasis 58 Balloon kyphoplasty 58 PROCRIT ® 58 Long Term Efficacy 58 Patellofemoral 58 esophageal manometry 58 Outpatient Setting 58 pyridostigmine 58 HepaMate 58 Outcome Measures 58 Transesophageal 58 NAVISTAR R 58 depression suicidal ideation 58 Inventory BPI 58 hemodialysis patients 58 serum aminotransferase levels 58 coronary stenosis 58 carotid artery blockage 58 included exfoliative dermatitis 58 anticholinergic agents 58 enthesitis 58 macrovascular events 58 hematopoietic cancers 58 Ebstein anomaly 58 Index CDAI 58 histologic findings 58 CT urography 58 prolonged QT interval 58 pharmacodynamics PD 58 coagulation disorders 58 metastatic neuroendocrine tumors 58 EEG abnormalities 58 untreated obstructive sleep 58 thromboembolic disease 58 nonpharmacologic 58 corticosteroids immunoglobulins 58 Fracture Risk 58 retrospective observational study 58 Hypocalcemia 58 preclinical efficacy 58 neutropenia thrombocytopenia 58 Juvenile Idiopathic Arthritis 58 cardiopulmonary bypass surgery 58 blood oxygen saturation 58 SGRQ 58 Coronary artery bypass grafting 58 Ribavirin causes 58 transabdominal 58 neuro trauma 58 Detrol Detrol LA 58 tolerability profiles 58 thrombotic complications 58 thrombo embolic 58 transaminase elevations 58 PSA nadir 58 Myocardial Infarction TIMI 58 Cardiac Defibrillators 58 Visual Analog Scale 58 Surgical Procedures 58 DCE MRI 58 coughing wheezing shortness 58 eculizumab therapy 58 XIENCE V PROMUS Stent 58 steroid refractory 58 colorectal adenoma 58 Pharmacodynamic 58 HAQ DI 58 erection hardness 58 spirometric 58 neuromuscular electrical stimulation 58 hepatic failure 58 gastrointestinal perforations 58 Clinical Relevance 58 transfusion syndrome 58 chronic metabolic acidosis 58 pharmacologic treatments 58 pain palliation 58 Teriflunomide 58 variant angina 58 Polysomnography 58 ImmuKnow 58 pressure monitoring ABPM 58 Thrombolysis 58 chondral 58 Chronic Renal Failure 58 ophthalmology dermatology 58 oral levofloxacin 58 intraobserver 58 Uncontrolled hypertension 58 natriuresis 58 atrioventricular block 58 Visual Analogue Scale VAS 58 transcranial Doppler ultrasound 58 pacemaker implantation 58 electrocardiography ECG 58 pretransplant 57 Biphasic 57 multivariable analyzes 57 transesophageal echocardiography 57 intracerebral haemorrhage 57 HRQoL 57 Vertebral Fractures 57 Pulse Oximeters 57 endovascular interventions 57 cerebral oximeter 57 hypervascular tumors 57 fatal anaphylactic 57 carotid artery stenosis 57 TMS Therapy 57 morbidity mortality 57 Atherosclerotic 57 Dr. Assa Amit 57 neuro stimulation 57 acute hepatic 57 laser Doppler 57 tamoxifen Nolvadex ® 57 MGN# 57 atrial tachyarrhythmias 57 atherothrombotic disease 57 Spectranetics laser 57 jugular venous 57 diabetes hypertension hyperlipidemia 57 neurologic impairment 57 Demonstrates Sustained 57 autonomic dysfunction 57 dyssynchrony 57 vascular reactivity 57 urologic diseases 57 tonsillar hypertrophy 57 vProtect TM Luminal Shield 57 KETEK 57 recurrent venous thromboembolism 57 cardiopulmonary disorders 57 efficacy tolerability 57 inotropic 57 Acute Decompensated Heart Failure 57 papilledema 57 recurrent ischemia 57 Ultrasonography 57 Postoperative 57 immunosuppression therapy 57 #-# Full Text 57 pharmacodynamic profiles 57 intima media thickness 57 constipation OIC 57 Ischemic 57 Angiographic 57 symptomatic paroxysmal AF 57 Amgen Neulasta R 57 symptomatic pulmonary embolism 57 ecchymosis 57 Postmarketing 57 orthopedics neurology 57 Health Assessment Questionnaire 57 Sociodemographic 57 bispectral index BIS 57 complement inhibitor eculizumab 57 hyper IgE syndrome 57 Telemonitoring 57 hypertension diabetes mellitus 57 nausea emesis 57 primary percutaneous coronary 57 RECIST Response Evaluation Criteria 57 epoetin alpha 57 clinically meaningful improvements 57 Adjunctive 57 color Doppler sonography 57 perioperative complications 57 computed tomography angiography 57 functional endoscopic sinus 57 repair TEVAR 57 myocardial contractility 57 pulmonary dysfunction 57 pulmonary toxicity 57 subthreshold depression 57 sociodemographic characteristics 57 MR Angiography 57 ventricular dilation 57 hepatic enzymes 57 electrolyte abnormalities 57 Physical Function 57 basal bolus regimen 57 neurophysiologic 57 Meta analyzes 57 ophthalmoscopy 57 Randomized Controlled Trials 57 VTE prophylaxis 57 intrathoracic 57 coagulopathy 57 renal scarring 57 #:#-#,# CrossRef Medline [002] 57 inhaled budesonide 57 multivariable Cox 57 Treatment Outcome 57 bi ventricular pacing 57 intracoronary 57 prospectively enrolled 57 transthoracic echocardiography 57 pulmonary artery hypertension 57 Xelox 57 neonatal pediatric 57 NNT = 57 oncologic outcomes 57 COR Analyzer 57 thrombocytosis 57 aspartate aminotransferase AST 57 Histopathologic 57 lipid lowering agents 57 Lung Injury 57 nerve conduction velocity 57 acetabular fractures 57 HeartNet 57 pulmonary alveolar 57 intraoperative complications 57 Acute Renal Failure 57 neuropsychological assessment 57 inotropes 57 hypoperfusion 57 HRQL 57 ACC NCDR 57 rheumatological 57 requiring ventilatory 57 Albuminuria 57 Depressive Symptoms 57 angiography CTA 57 ECLS 57 Clinical Outcome 57 systolic function 57 Endothelial function 57 tumor histology 57 Subarachnoid hemorrhage 57 StO2 57 RVOT 57 Claudication 57 postoperative atrial fibrillation 57 GH deficiency 57 Inhaled Nitric Oxide 57 PASI scores 57 polysomnography PSG 57 vasomotor 57 Rheos System 57 elevated transaminases 57 bronchopulmonary dysplasia BPD 57 prognostic variables 57 tachyarrhythmia 57 CT perfusion 57 CTEPH 57 glaucomatous 57 NIH CPSI 57 Comorbid 57 Interrater reliability 57 enzyme immunoassay EIA 57 elevated creatinine 57 SpCO 57 REMINDER ORLive Presents 57 transcatheter closure 57 cystic fibrosis chronic pancreatitis 57 percutaneous interventions 57 subjective sleepiness 57 cerebral vasospasm 57 urodynamic 57 Left ventricular hypertrophy 57 spirometers 57 Patient Outcomes 57 atherothrombotic 57 GRNCM1 57 EMBLEM TM 57 CYT# potent vascular disrupting 57 NIASPAN 57 acute ischemia 57 Scale PANSS 57 percutaneous drainage 57 liver histology 57 Hyperparathyroidism 57 microangiopathy 57 DEFINITY ® 57 RenalGuard Therapy 57 hepatic function 57 thorough QT 57 endocrinology gastroenterology 57 Fetal Fibronectin Test 57 affective psychosis 57 CARESCAPE Monitor B# 57 gross hematuria 57 fatty degeneration 57 analgesic medications 57 Urinary tract 57 prospective nonrandomized 57 INFERGEN 57 parkinsonian symptoms 57 gastroenterology neurology 57 arteritis 57 genitourinary GU 57 comorbid depression 57 arterial calcification 57 diastolic pressures 57 acute subacute 57 UPDRS motor 57 Prognostic significance 57 psoriatic arthritis PsA 57 hypertension congestive heart 57 antiretroviral naïve 57 opioid naïve 57 capillary leakage 57 fusion enhancers 57 glomerular filtration 57 categories Glucose Monitoring 57 hemoglobin hematocrit 57 Pharmacokinetic parameters 57 heparin induced thrombocytopenia 57 β blockers 57 hippocampal sclerosis 57 LVAD implantation 57 osteoid osteoma 57 Intravascular 57 Cardiac resynchronization therapy 57 IOP lowering 57 pacemakers implantable cardioverter defibrillatorsHELB 57 microbiologically evaluable 57 ICD shocks 57 histological subtypes 57 dyspnoea 57 unstable angina UA 57 Val HeFT 57 pericardial effusion 57 dimensional echocardiography 57 DAS# CRP 57 fatty infiltration 57 neurosciences orthopedics 57 oncology dermatology 57 GEM OS2 57 brachial artery flow 56 Chemotherapy induced 56 OptiVol ® 56 evaluate ZFP Therapeutic 56 RE LY ® 56 prospective multicentre 56 voiding dysfunction 56 Valvular 56 diffusion tensor 56 branch retinal vein 56 superior mesenteric artery 56 psychiatric morbidity 56 Kaplan Meier curve 56 cardiopulmonary bypass CPB 56 INVEGA ® 56 tissue oxygen saturation 56 Intubation 56 Alzheimer Disease Assessment 56 adverse cytogenetics 56 immune reconstitution syndrome 56 TLIF 56 neonatal morbidity 56 antipsychotic prescribing 56 intratympanic 56 Hypercholesterolemia 56 SpO 2 56 Services #:#-#,# Abstract 56 noncardiovascular mortality 56 dysrhythmias 56 ischemia induced 56 Polypharmacy 56 antithrombotic therapy 56 oxygen saturation SpO2 56 micronutrient supplementation 56 Percutaneous Tibial Nerve Stimulation 56 acute myocardial ischemia 56 cardiac malformations 56 NSAID induced GI 56 undergoing cardiac catheterization 56 Seattle Angina Questionnaire 56 ventilation perfusion 56 hemoglobinopathies 56 ascending aortic 56 semiquantitative 56 papillary renal cell carcinoma 56 cortical atrophy 56 interferon ribavirin 56 physiologic parameters 56 thoracic aortic 56 preoperative diagnosis 56 invasive angiography 56 Picis Perioperative Dashboard 56 Infarct 56 Score TOS 56 Pharmacokinetic 56 intraventricular 56 anaphylaxis dyspnea flushing 56 neurologic complications 56 Percutaneous vertebroplasty 56 Thrombus Aspiration 56 Minimally Invasive Procedure 56 inflammatory biomarkers 56 anastomotic leak 56 hypothalamic pituitary adrenal axis 56 NMR LipoProfile test 56 bronchoscopic procedure 56 silent ischemia 56 noncardiac 56 ST Segment Elevation 56 thoracic aortic aneurysm 56 neurologic abnormalities 56 prostate abnormalities 56 ejection fractions 56 fundus photography 56 audiometric 56 hemodynamically unstable 56 reactive hyperemia 56 artery occlusion 56 mechanically ventilated patients 56 Bispectral Index 56 hepatic renal 56 interstitial brachytherapy 56 immune thrombocytopenic purpura 56 bronchodilatory 56 Univariate 56 ski lls 56 bacterial prostatitis 56 affective psychoses 56 histologically proven 56 non valvular atrial 56 Hematologic 56 analgesic efficacy 56 diaphoresis 56 cystoid macular edema 56 oncological outcomes 56 Electrophysiological 56 Intravitreal 56 Oncophage vaccination 56 pharmacodynamic properties 56 abnormal lipid 56 ADCS ADL 56 opioid naive 56 Stenosis 56 platelet dysfunction 56 pre operatively 56 Venous thromboembolism 56 polyarticular 56 Coronary stents 56 CTAP# Capsules 56 gastrointestinal GI motility disorders 56 Ocular Surface Disease 56 Neuropsychiatric Inventory NPI 56 AneuRx 56 pericardial effusions 56 undergoing peritoneal dialysis 56 transvaginal sonography 56 osteoporotic compression fractures 56 urethral strictures 56 epidural analgesia 56 nonvertebral fracture 56 Crohn Disease Activity 56 arteriography 56 serum lipid 56 Montgomery Asberg Depression 56 gynecology pediatrics 56 pharmacodynamic endpoints 56 VIIBRYD 56 COPD asthma 56 Post operatively 56 obstructive CAD 56 Key secondary endpoints 56 multivariate Cox 56 metaanalysis 56 Evaluable 56 Accessed #/#/# [001] 56 SpO2 56 LVNC 56 RoACTEMRA 56 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 56 cardiology urology 56 elevated LDH 56 visceral metastases 56 ischemic cardiomyopathy 56 cCTA 56 myocardial ischaemia 56 anaphylactic reactions bronchospasm 56 nasal symptom 56 radiographic findings 56 spine deformities 56 severely immunosuppressed 56 paracentesis 56 CRp 56 seizures miscarriages 56 serum lipid levels 56 Intravenous immunoglobulin 56 Carotid 56 hyperacute 56 resynchronization therapy 56 leucopenia 56 #beta estradiol 56 Amgen Neulasta ® 56 diarrhea dyspepsia 56 IMPACT DCM 56 chronic renal disease 56 CIBIC plus 56 acetabular dysplasia 56 preoperative PSA 56 needle electromyography procedures 56 Electrocardiogram ECG 56 preintervention 56 left ventricular LV 56 erythema nodosum 56 angioplasties stents 56 rhITF 56 Main Outcome Measure 56 Maven Semantic 56 bioprosthetic valve 56 extracranial 56 pulsed Doppler 56 recovery CRp 56 undergoing CABG 56 thyrotropin levels 56 serologic testing 56 Randomized Trials 56 Carotid artery 56 BARACLUDE r 56 lesional 56 Myocardial 56 ventricular repolarization 56 HeFH 56 arteriovenous fistulas 56 periodically reassessed 56 cleft lip cleft palate 56 cerebrovascular events 56 Postoperatively 56 plasma pharmacokinetics 56 cardiac troponin 56 BoNTA 56 NUCYNTA ™ 56 methotrexate monotherapy 56 antiangiogenic therapy 56 polytherapy 56 Clinically significant 56 ACTEMRA TM 56 Injury Severity Score 56 intradermal injections 56 osteoporotic vertebral fractures 56 Electrocardiography 56 ANN INTERN MED 56 spinal metastases 56 neurocognitive function 56 ICD therapy 56 corneal thickness 56 pressure tachycardia diaphoresis 56 Balloon Kyphoplasty 56 NMDA antagonists 56 retrospective cohort 56 Fluid retention 56 Renal Insufficiency 56 J Foot Ankle 56 revascularization procedures 56 postoperative morbidity 56 gastro esophageal reflux 56 Sentinel Lymph Node 56 conventional angiography 56 OptiVol 56 valve implantation 56 neurologic outcomes 56 FXIII 56 pathological fractures 56 posterolateral fusion 56 hypobaric chambers 56 neutropaenia 56 peripheral vascular diseases 56 parenchymal 56 total cholesterol triglycerides 56 neovascularisation 56 SPECT CT imaging 56 serum bicarbonate 56 postmarketing adverse 56 NMES 56 rheumatoid arthritis osteoarthritis ankylosing 56 premorbid 56 mitral regurgitation MR 56 WOMAC scores 56 Levels Linked 56 Subgroup Analysis 56 APTIVUS R 56 containing abacavir 56 Heavy menstrual bleeding 56 intracranial stenosis 56 postsurgical pain 56 nontraumatic 56 Coronary artery bypass graft 56 Pharmacologic 56 neuromotor 56 resting ECG 56 syncope fainting 56 discontinued Viread 56 CYPHER ® 56 albumin excretion rate 56 intracranial atherosclerosis 56 coagulation assays 56 pharmacokinetic parameters 56 genotypic resistance 56 Multivariable 56 mu opioid agonists 56 rituximab refractory follicular 56 radiation dosimetry 56 telemonitoring imaging 56 leiomyomas 56 neurocognitive impairment 56 cardioverter defibrillators 56 NYHA functional class 56 lumbar disk herniation 56 patientswith 56 agitation hallucinations 56 mitral annular 56 overactive bladder syndrome 56 aspirin cholesterol lowering 56 torsade de pointes 56 urate lowering 56 -#.# log# copies mL 56 psychopathological symptoms 56 near infrared spectroscopic 56 carotid artery stenting CAS 56 transcutaneous electrical nerve 56 severe mitral regurgitation 56 renal insufficiency 56 Carotid Endarterectomy 56 cardiopulmonary fitness 56 histological subtype 56 thromboembolism 56 acute myocardial infarction congestive 56 Kidney Function 56 anastomotic devices 56 Captopril 56 CareFocus 56 antiarrhythmic drug 56 proximal humeral fractures 56 Nonspecific 56 Elastography 56 fluorescein angiography 56 Implantable Cardioverter Defibrillator ICD 56 β blocker 56 dosimetric 56 oncology radiation oncology 55 Nonsurgical 55 aldosterone antagonists 55 cytogenic 55 Pharmacodynamics 55 Tambocor 55 Deep venous thrombosis 55 thickness IMT 55 acute GVHD 55 Febrile neutropenia 55 overt nephropathy 55 multivariable adjusted 55 Spinal cord 55 FibroScan 55 plasma creatinine 55 Cystatin C 55 nonaspirin 55 thoracoscopic lobectomy 55 virologic responses 55 Persistent Sleep 55 GAMMAGARD 55 bolus dose 55 Computed tomographic 55 thrombophlebitis 55 nasal obstructions 55 comorbid disorders 55 nitroprusside 55 HIV coinfected 55 ACR# ACR# 55 nausea diarrhea fatigue 55 Arterial stiffness 55 allogenic stem cell 55 MDCT angiography 55 prospective observational studies 55 unexplained syncope 55 upper endoscopies 55 rhythm disturbances 55 orthopedics oncology 55 esophagogastroduodenoscopy 55 intracranial hypertension 55 EtCO2 55 pharmacokinetics PK 55 Visual acuity 55 comorbid conditions 55 Adverse Event 55 neuro vascular 55 Improves Patient 55 Intracranial 55 inotropic agents 55 electroencephalographic 55 wilate ® 55 HRQOL 55 percutaneous biopsy 55 Degenerative Disc Disease 55 abnormal clotting 55 vomiting PONV 55 rheumatologic 55 Severity MSCS score 55 abdominal computed tomography 55 DVT PE 55 ADVEXIN therapy 55 Bioavailability 55 Stent Thrombosis 55 infarction NSTEMI 55 myocardial infarct size 55 glycoprotein IIb IIIa inhibitor 55 p# biomarker 55 ADAS cog 55 nonischemic 55 erythrocyte sedimentation rate

Back to home page